102 related articles for article (PubMed ID: 9761101)
1. Usefulness of intravenous metoprolol to prevent syncope induced by head-up tilt.
Kluger J; Bazunga M; Goldman R; O'Rangers E; Azar P; Chow MS
Am J Cardiol; 1998 Sep; 82(6):820-3, A10. PubMed ID: 9761101
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt.
Morillo CA; Leitch JW; Yee R; Klein GJ
J Am Coll Cardiol; 1993 Dec; 22(7):1843-8. PubMed ID: 8245337
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of intravenous metoprolol during positive isoproterenol tilt-table test in the choice of treatment for neurocardiogenic syncope.
Baran I; Gemici K; Ozdemir B; Saraç M; Güllülü S; Aydinlar A; Cordan J
Indian Heart J; 2003; 55(1):40-3. PubMed ID: 12760586
[TBL] [Abstract][Full Text] [Related]
4. Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope.
Sra JS; Murthy VS; Jazayeri MR; Shen YH; Troup PJ; Avitall B; Akhtar M
J Am Coll Cardiol; 1992 Feb; 19(2):402-8. PubMed ID: 1346266
[TBL] [Abstract][Full Text] [Related]
5. Prolonged asystole during head-up tilt table testing after beta blockade.
Dangovian MI; Jarandilla R; Frumin H
Pacing Clin Electrophysiol; 1992 Jan; 15(1):14-6. PubMed ID: 1370994
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons.
Müller G; Deal BJ; Strasburger JF; Benson DW
Am J Cardiol; 1993 Mar; 71(7):592-5. PubMed ID: 8438747
[TBL] [Abstract][Full Text] [Related]
7. Response to beta blockers in patients with neurocardiogenic syncope: how to predict beneficial effects.
Natale A; Newby KH; Dhala A; Akhtar M; Sra J
J Cardiovasc Electrophysiol; 1996 Dec; 7(12):1154-8. PubMed ID: 8985804
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope.
Sheldon R; Connolly S; Rose S; Klingenheben T; Krahn A; Morillo C; Talajic M; Ku T; Fouad-Tarazi F; Ritchie D; Koshman ML;
Circulation; 2006 Mar; 113(9):1164-70. PubMed ID: 16505178
[TBL] [Abstract][Full Text] [Related]
9. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole.
Sra JS; Jazayeri MR; Avitall B; Dhala A; Deshpande S; Blanck Z; Akhtar M
N Engl J Med; 1993 Apr; 328(15):1085-90. PubMed ID: 8455666
[TBL] [Abstract][Full Text] [Related]
10. Tilt-table testing and oral metoprolol therapy in young patients with unexplained syncope.
O'Marcaigh AS; MacLellan-Tobert SG; Porter CJ
Pediatrics; 1994 Feb; 93(2):278-83. PubMed ID: 8121741
[TBL] [Abstract][Full Text] [Related]
11. Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine.
Biffi M; Boriani G; Sabbatani P; Bronzetti G; Frabetti L; Zannoli R; Branzi A; Magnani B
Heart; 1997 Mar; 77(3):268-72. PubMed ID: 9093048
[TBL] [Abstract][Full Text] [Related]
12. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope.
Cox MM; Perlman BA; Mayor MR; Silberstein TA; Levin E; Pringle L; Castellanos A; Myerburg RJ
J Am Coll Cardiol; 1995 Nov; 26(5):1293-8. PubMed ID: 7594046
[TBL] [Abstract][Full Text] [Related]
13. The usefulness of tilt testing with an intravenous beta-blocker in assessing the efficacy of long-term therapy in patients with vasovagal syncope.
Gielerak G; Makowski K; Dłuzniewska E; Stec A; Cholewa M
Kardiol Pol; 2003 Aug; 59(8):93-104; commentary 103-4. PubMed ID: 14560324
[TBL] [Abstract][Full Text] [Related]
14. Norepinephrine transporter inhibition prevents tilt-induced pre-syncope.
Schroeder C; Birkenfeld AL; Mayer AF; Tank J; Diedrich A; Luft FC; Jordan J
J Am Coll Cardiol; 2006 Aug; 48(3):516-22. PubMed ID: 16875978
[TBL] [Abstract][Full Text] [Related]
15. Failure of propranolol to prevent tilt-evoked systemic vasodilatation, adrenaline release and neurocardiogenic syncope.
Eldadah BA; Pechnik SL; Holmes CS; Moak JP; Saleem AM; Goldstein DS
Clin Sci (Lond); 2006 Sep; 111(3):209-16. PubMed ID: 16634720
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of intravenous granisetron for prevention of neurally mediated hypotension upon head upright tilt testing.
Tsikouris JP; Kluger J; Chow MS; White CM
Am J Cardiol; 2000 May; 85(10):1262-4. PubMed ID: 10802016
[No Abstract] [Full Text] [Related]
17. Reproducibility of head-up tilt-table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease.
Chen XC; Chen MY; Remole S; Kobayashi Y; Dunnigan A; Milstein S; Benditt DG
Am J Cardiol; 1992 Mar; 69(8):755-60. PubMed ID: 1546650
[TBL] [Abstract][Full Text] [Related]
18. The effect of atropine in vasovagal syncope induced by head-up tilt testing.
Santini M; Ammirati F; Colivicchi F; Gentilucci G; Guido V
Eur Heart J; 1999 Dec; 20(23):1745-51. PubMed ID: 10562483
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of the efficacy of metoprolol and verapamil in patients with syncope and positive head-up tilt test response.
Jhamb DK; Singh B; Sharda B; Kaul U; Goel P; Talwar KK; Wasir HS
Am Heart J; 1996 Sep; 132(3):608-11. PubMed ID: 8800032
[TBL] [Abstract][Full Text] [Related]
20. Assessment of left ventricular volume by an ambulatory radionuclide monitoring system during head-up tilt in patients with unexplained syncope: relation to autonomic activity assessed by heart rate variability.
Hosaka H; Takase B; Kitamura K; Uehata A; Satomura K; Isojima K; Kosuda S; Kusano S; Kurita A; Ohsuzu F
J Nucl Cardiol; 2001; 8(6):660-8. PubMed ID: 11725262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
